Entheon Biomedical Corp.

OTCPK:ENTB.F Stock Report

Market Cap: US$657.6k

Entheon Biomedical Balance Sheet Health

Financial Health criteria checks 4/6

Entheon Biomedical has a total shareholder equity of CA$293.8K and total debt of CA$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CA$335.4K and CA$41.6K respectively.

Key information

0%

Debt to equity ratio

CA$0

Debt

Interest coverage ration/a
CashCA$299.14k
EquityCA$293.83k
Total liabilitiesCA$41.55k
Total assetsCA$335.38k

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: ENTB.F's short term assets (CA$330.4K) exceed its short term liabilities (CA$41.6K).

Long Term Liabilities: ENTB.F has no long term liabilities.


Debt to Equity History and Analysis

Debt Level: ENTB.F is debt free.

Reducing Debt: ENTB.F had no debt 5 years ago.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: ENTB.F has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: ENTB.F has less than a year of cash runway if free cash flow continues to grow at historical rates of 39.2% each year.


Discover healthy companies